Abeona Therapeutics Inc. (ABEO)
市前：
| 前收市價 | 3.4100 |
| 開市 | 3.4500 |
| 買盤 | 3.1500 x 100 |
| 賣出價 | 3.2000 x 200 |
| 今日波幅 | 3.1400 - 3.5200 |
| 52 週波幅 | 2.8300 - 9.0100 |
| 成交量 | |
| 平均成交量 | 492,553 |
| 市值 | 86.715M |
| Beta 值 (5 年，每月) | 1.48 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.5300 |
| 業績公佈日 | 2024年5月09日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 20.50 |
Insider MonkeyAbeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2023 Earnings Call Transcript
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2023 Earnings Call Transcript November 16, 2023 Operator: Greetings, and welcome to the Abeona Therapeutics Third Quarter 2023 Conference Call. [Operator Instructions]. Please note this conference is being recorded. I will now turn the conference over to your host, Mr. Greg Gin. Sir, you may begin. Greg Gin: Thank you, […]
InvestorPlace3 Biotech Blockbusters to Turn $5,000 Into $50,000
Investing in biotech stock can provide investors with immense rewards but also substantial risks. The key is finding the right balance. With diligent research, it’s possible to identify promising companies that appear undervalued relative to their blockbuster prospects. Their innovative therapies could be game-changers, and clinical trial successes could lead to surges in share price. However, inherent risks in biotech investing cannot be overlooked. That’s because the outcomes for these stocks
